Acute myeloid leukemia( AML ) is a clonal and heterogeneous disease characterized by a myriad of genetic defects. 急性髓性白血病 ( acutemyeloid leukemia, AML ) 是一类起源于造血干细胞的、以大量遗传缺陷为特征的异质性恶性血液病. 互联网 Methods: Induction regiment ofacute myeloid leukemia( AML ) co...
aWhat a meaningless sense if losing myself,though owning all of the world 无意义的感觉,如果失去,虽则拥有所有世界[translate] aAcute myeloid leukemia; 急性骨髓状白血病;[translate]
Acute myeloid leukemia (AML) is also called acute myelogenous leukemia. It is a fast-growing cancer of the bone marrow and blood cells. Cells that should become white blood cells (WBCs) do not fully grow. These cells are called myeloblasts and monoblasts. They do not fight infection like...
Acute myeloid leukemia (AML) has been treated with combination chemotherapy, hematopoietic stem cell transplantation (HSCT) and differentiation induction therapy. Intensive induction and consolidation therapy including high dose cytarabine (HDAC) is ...
Related to acute myeloid leukemia:Chronic Myeloid Leukemia ThesaurusAntonymsRelated WordsSynonymsLegend: Switch tonew thesaurus Noun1. acute myeloid leukemia- acute leukemia characterized by proliferation of granular leukocytes; most common in adolescents and young adults ...
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. In AML, the bone marrow makes abnormal red blood cells, platelets, or myeloblasts (a type of immature white blood cell). These abnormal cells are called “blasts” and are the leukemia cells. These cells ...
How acute myeloid leukemia affects you depends on certain things, including how well it responds to treatment. Your outlook is better if: You’re younger than 60. You have a lower white blood cell count when you're diagnosed. You haven’t had other blood disorders or cancers. ...
Acute Myeloid Leukemia Diane C. Farhi GENERAL FEATURES Nomenclature Acute leukemia arising from myeloid cells has been variously referred to as myeloblastic, myelocytic, and myeloid, with little, if any, clarification as to the meaning implied by these different terms. In this chapter, the overall ...
There are few molecular biologic determinants that are prognostic for patients with acute myeloid leukemia (AML). Hence, we examined whether cellular levels of the cyclin-dependent kinase inhibitor p27in acute myeloid leukemia could be used to predict clinical outcome in AML. Using immunoblot ...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as mutations in the genes involved in hematopoietic prolifer